Long-term follow-up of people given the gene-editing treatment PBGENE-HBV for chronic hepatitis B
Follows people with chronic HBV infection who earlier received PBGENE-HBV.
Plain-language title generated from the registry record
Registry title: A Long-term Observational Study in Participants Who Have Received PBGENE-HBV
Key facts
- Where
- Chisinau, MoldovaSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 19 and 80 years old?
Source: NCT07254208, who can take part
Where in Moldova
- ICS ARENSIA Exploratory Medicine SRLChisinau, MoldovaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Precision BioSciences, Inc.
- Trial code
- NCT07254208
- Record updated
- 22 April 2026
- Original description
Participants who received at least one dose of PBGENE-HBV will be enrolled in this LTFU study.Read full original descriptionShow less
A Long-term Observational Study in Participants Who Have Received PBGENE-HBV, an In Vivo Gene Editing Investigational Product, in a Prior Clinical Study
Participants who received at least one dose of PBGENE-HBV will be enrolled in this LTFU study.
Inclusion: Participant has received at least 1 dose of PBGENE-HBV investigational product in a prior clinical study; Participant, or their legally authorized representative, has provided signed informed consent.
Exclusion: N/A.